Skip to main content

Changes to 49 CFR Part 40, Procedures for Transportation Workplace Drug and Alcohol Testing Programs Effective October 1, 2010


Mobile Medical Corporation (MMC)
 Drug Testing Industry Alert!

Introduction
The Omnibus Transportation Employees Testing Act (Omnibus Act) requires the Department of Transportation (DOT) to follow Department of Health and Human Services (DHHS) requirements for testing procedures/protocols and drugs. Most of the changes to 49 CFR Part 40 were made to meet specific DHHS guidelines for laboratory procedures, drug cut-off levels, and drugs. These guidelines apply to federal employees and employees in federally regulated industries, such as transportation and nuclear, as well as state regulations that mandate compliance with DHHS guidelines.

Changes
On October 1, 2010, The following changes to the DHHS and DOT drug testing panel will be required:

Amphetamines
§ Decrease the Amphetamines screening cutoff from 1000 ng/mL to 500 ng/mL;

§ Decrease the confirmation cutoff of both amphetamine and methamphetamine from 500 ng/mL to 250 ng/mL;

§ Only MDMA is added as a specific target drug for screening; MDMA, MDA and MDEA are included in confirmation testing.

Testing for MDMA (Ecstasy)
MDMA will be a target analyte in the amphetamines screening assay, with confirmation testing for MDMA, MDA, and MDEA.

6-Monoacetylmorphine (heroin metabolite)
§ Addition of a specific screening test for the heroin metabolite at 10 ng/mL cutoff concentration. This change requires a laboratory to confirm and report the heroin metabolite by itself, in contrast to the current Guidelines policy that requires the heroin metabolite to be tested and reported in conjunction with a positive morphine result. Recent data indicates that the heroin metabolite is present in
specimens even when the morphine concentration is below 2000 ng/mL.

Cocaine
§ Decrease the Cocaine metabolite screening cutoff from 300 ng/mL to 150 ng/mL

§ Decrease the Cocaine metabolite confirmation cutoff from 150ng/mL to 100ng/mL

How Will These Changes Affect You?
Although Non-DOT regulated testing programs are not required to implement these upcoming changes (except where required by law),

Industry consensus is that most non-DOT regulated program owners and employers will most likely make changes to follow the new

guidelines. As the new revisions will take effect soon you may need to consider a few issues regarding drug testing program.
Some issues to consider...

Will you revise your testing panel to comply with the new government revisions? Will adding the new screens increase costs?

Do you belong to an association, a labor-management cooperative program or other organization that requires you to follow DHHS guidelines? How will their changes affect or change your program?

Are you in a State with a “Drug Free Work Place” Program that requires you to mirror the new regulations in order to bid state funded projects?

Need Advice?
Part 40 Final Rule is effective October 1, 2010 and a copy of the Federal Register Notice is available on our Website under Latest News. DOT-regulated employers should ensure that their policies include the updated definitions, drugs tested for, and cut-off levels in their policy. If you have questions about the Part 40 Final Rule, please contact  877-688-8358.

Popular posts from this blog

New Oxycodone Formula Gets Backing of FDA

The FDA recently voted in favor of pushing a new formulation of oxycodone hydrochloride for approval. The new OxyContin formula is more difficult to crush or dissolve which will hopefully make it harder to be used as a drug of abuse . The FDA recommended that Purdue Pharma's application for a new, resin-coated formulation should replace the original version, which has been on the market since 1996. Randall Flick, MD, an anesthesiologist at the Mayo Clinic who voted to recommend approval of the drug said, "Clearly the old formulation is worse than the new, although I think the difference is relatively small," Flick concluded, "Hardcore abusers are likely to devise new ways to break down the harder tablet or figure out which solvents will dissolve it fastest, within 'day or weeks' of the product's release on the market."
Read more

Utah Debates Drug Testing for Public Assistance

Utah has begun to follow the path that so many other states have traveled earlier this year. The path leads to drug testing for public assistance. Utah Senator Dennis Stowell had asked that the issue be studied carefully and Rep. Christopher Herrod said "If someone's on drugs, we shouldn't be giving them money," he said. "There's nowhere in the Constitution that says, 'You have a right to get welfare." At the center of the debate is cost and legality. An analyst for Community Action Partnership of Utah stated that "The cost to test all Utah’s families that receive 'Temporary Assistance for Needy Families' would be high." The analyst added, "That testing all welfare recipients just once would cost about $255,000 and a lawsuit against the state would likely cost more than $1 million." Further discussion and analysis is planned in the upcoming months to decide whether to study the issue further, table the issue or wait un
Read more

PHOTOS: MMC Through the Years

Mobile Medical Corporation (MMC) is excited to be celebrating our 30th Anniversary in 2020! MMC was founded on June 21, 1990. Check out some photos as we have grown over the years!            
Read more